Rosen Law says Capricor investors may join securities class action
Rosen Law Firm said investors who bought Capricor Therapeutics securities during the class period may be eligible to join an existing securities class action, with a lead-plaintiff deadline of Sept. 28, 2026.
Rosen Law Firm said investors who bought Capricor Therapeutics securities during the class period may be eligible to join an existing securities class action, with a lead-plaintiff deadline of Sept. 28, 2026.
Rosen Law Firm said Aug. 24 that purchasers of Capricor Therapeutics securities between Dec. 17, 2025, and July 26, 2026, may be able to join a securities class action involving the biotechnology company. The notice said investors seeking to serve as lead plaintiff must move the court by Sept. 28, 2026.
According to the notice, a class action has already been filed and eligible investors may seek compensation through the case. Rosen said investors may participate under a contingency fee arrangement, with no out-of-pocket fees or costs.
According to the PR Newswire notice, the lawsuit alleges Capricor changed the pre-specified statistical analysis plan used to analyze clinical data for Deramiocel. The notice says the complaint alleges the Food and Drug Administration had not agreed to those changes before Capricor resubmitted the Deramiocel biologics license application.
The notice also says the lawsuit alleges there was a significant risk the FDA could conclude the clinical results did not provide substantial evidence of effectiveness and that there was a substantial risk to regulatory approval of Deramiocel for Duchenne muscular dystrophy. It says the complaint claims positive statements about Capricor's business, operations and prospects were materially misleading or lacked a reasonable basis.
Capricor Therapeutics is listed on Nasdaq under the ticker CAPR, according to the notice. The filing identifies the class period as Dec. 17, 2025, through July 26, 2026, inclusive.
The notice defines a lead plaintiff as a representative party who acts on behalf of other class members in directing the litigation. Rosen also listed a toll-free phone number, an email address and a web link for investors who want to join the case.
The notice did not include a response from Capricor. The next procedural milestone cited in the notice is the Sept. 28, 2026, deadline for investors seeking lead-plaintiff status.
Sources
Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.
View the Web StoryA visual, tap-through version of this reportThis is the AMP version of the article. Read the full article on Atlas Watchline.